Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 263-264

Informa Healthcare

Access to resources Recommend Favorite

The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma

By Chi D.S.   Venkatraman E.S.   Masson V.   Hoskins W.J.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite

Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer

By Bristow R.E.   Montz F.J.   Lagasse L.D.   Leuchter R.S.   Karlan B.Y.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 278-287

Elsevier

Access to resources Recommend Favorite

Clinical Outcome of Tertiary Surgical Cytoreduction in Patients with Recurrent Epithelial Ovarian Cancer

By Fotopoulou Christina  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 49-57

Springer Publishing Company

Access to resources Recommend Favorite

Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer

By Covens A.   Carey M.   Bryson P.   Verma S.   Fung Kee Fung M.   Johnston M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 71-80

Elsevier

Access to resources Recommend Favorite